Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-12-069727
Filing Date
2012-12-27
Accepted
2012-12-27 06:21:02
Documents
1
Period of Report
2012-12-27

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v330981_6k.htm 6-K 8696
  Complete submission text file 0001144204-12-069727.txt   9611
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 121286212
SIC: 2834 Pharmaceutical Preparations